Inhibiting the expression of MALAT1 can reduce ALP activity and inhibit osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) by enhancing the activation of the MAPK signaling pathway that promotes the progression of osteoporosis (Zheng et al., 2019). Here, MALAT1 is linked to osteoporosis.